Poster Presentations P175 POSTERS KATH hospital in Ghana. 2) Compare QOL of these patients with a healthy Ghanaian population. 3) Compare QOL for Ghanian patients with QOL of head and neck cancer patients in the United States.
Method: Data collection is ongoing. We anticipate inclusion of 30 Ghanaian head and neck cancer patients, and 30 healthy Ghanaian controls. Participants complete the FACT-H+N QOL Questionnaire. Data for patients in the United States are obtained from the FACIT database. Outcome measures include means, medians, standard deviations, and analysis of variance.
Results: Preliminary results demonstrate lower QOL scores among Ghanaian patients undergoing treatment compared with healthy controls (94.5 vs 111). Patients undergoing treatment also have lower scores for physical well-being (22.5 vs 26.4), functional well-being (14 vs 18.5), and head and neck-specific symptoms (20.5 vs 36.4). Ghanaians undergoing treatment had higher scores for emotional well-being compared with healthy Ghanaians (22 vs 16.1). Initial comparison of the Ghanaian and American treatment groups revealed similar scores for physical well-being (22.5 vs 18.9) and functional impairment (14 vs 15.3). However, the Ghanaian patients had higher scores for emotional well-being (22 vs 16.8).
Conclusion: QOL of Ghanaian head and neck cancer patients is significantly worse than healthy controls. Patients are most affected by physical and functional impairments. Emotional well-being is not worse for Ghanaians undergoing treatment. Ghanaian patients are similar to Americans in physical and functional well-being. However, Ghanaian patients demonstrate greater sense of emotional well-being.
Head and Neck Surgery Quality-of-Life tools in Oral and Oropharyngeal Cancer
Sami P. Moubayed, MD (presenter); John S. Sampalis; Apostolos Christopoulos, MD Objective: 1) To identify and evaluate patient-reported quality of life (QOL) questionnaires used in studies of oral and oropharyngeal cancer. 2) To provide information on the trends of use of each questionnaire according to language, country of origin, publication date, and type of treatment.
Method: Systematic review of the English-language literature. A search using the Medical Subject Headings (MeSH) queries ("Oropharyngeal Neoplasms" OR "Mouth Neoplasms") AND "Quality of Life" was carried out by using a publicly available MEDLINE interface (PubMed). A total of 371 articles were identified and reviewed. We identified all English-language studies of oral or oropharyngeal cancer patients that measure QOL using a patient-reported questionnaire. Exclusion criteria are review article, comment, non-English-language study, wrong disease, and absence of quality of life measure.
Results: Identified questionnaires will be summarized. Each instrument will be compared against the standards for health outcome instrument development and evaluation of the Scientific Advisory Committee of the Medical Outcomes Trust.Descriptive statistics regarding identified studies will be presented regarding questionnaire use by language, country of origin, publication date, and type of treatment.
Conclusion:
Our results will help identify well-researched areas in patient-reported measures of QOL, and areas where more research is required. This is also the first study to objectively measure the number of studies that use each patient-reported QOL questionnaire according to language, country of origin, publication date, and type of treatment. Such data is crucial in helping adequate questionnaire selection for evaluation of QOL. Results: Out of 23 cases, 17 were rare malignancies of the parapharyngeal space. Of these, 6 tumors arose de novo (sarcoma, squamous cell carcinoma, synovial sarcoma, fibrosarcoma, rhabdomyosarcoma, and leiomyosarcoma) and 3 were direct extension of deep lobe parotid tumor (undifferentiated carcinoma with neck metastasis). Other rare tumors were extra osseous chordoma of the parapharyngeal space (n = 1), malignant fibrous histiocytoma (n = 1), malignant ameloblastoma (n = 1), malignant melanoma extending to the infratemporal fossa (n = 1), malignant schwannoma (n = 1), malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (triton tumor; n = 1), neurofibroma with atypia (n = 1), and extraosseus Ewing's sarcoma (n = 1). Fourteen out of 23 (60.8%) patients are alive with no evidence of disease on variable follow up with mean follow up of 15 months.
Head and Neck Surgery
Conclusion: Tumors of the parapharyngeal space are uncommon, comprising less than 1% of all head and neck neoplasms. Accurate diagnosis and management is challenging and requires a team approach. When the diagnosis is ambiguous, a complete surgical excision and histopathological examination should be the preferred approach for these rare tumors.
